T1	Procedure 82 94	chemotherapy
T2	Procedure-Name 82 94	chemotherapy
T3	Procedure 97 110	immunotherapy
T4	Procedure-Name 97 110	immunotherapy
T5	Modifier 113 123	biological
T6	Modifier 126 134	targeted
T7	Procedure 140 157	radiation therapy
T8	Procedure-Name 140 157	radiation therapy
T9	Study 161 176	investigational
T10	Drug 177 182	agent
T11	Modifier 185 196	therapeutic
T12	Modifier 200 210	diagnostic
T13	Eq-Comparison 213 227	within 3 weeks
T14	Eq-Operator 213 219	within
T15	Eq-Value 220 221	3
T16	Eq-Temporal-Unit 222 227	weeks
T17	Study 248 253	study
T18	Drug 254 264	medication
T19	Severity 267 272	Major
T20	Procedure 273 280	surgery
T21	Procedure-Name 273 280	surgery
T22	Exception 283 293	other than
T23	Procedure 294 312	diagnostic surgery
T24	Procedure-Name 294 312	diagnostic surgery
T25	Eq-Comparison 315 329	within 4 weeks
T26	Eq-Operator 315 321	within
T27	Eq-Value 322 323	4
T28	Eq-Temporal-Unit 324 329	weeks
T29	Eq-Comparison 337 342	first
T30	Eq-Temporal-Recency 337 342	first
T31	Study 343 348	study
T32	Drug 349 353	drug
T33	Severity 376 387	Significant
T34	Condition 388 395	cardiac
T35	Eq-Comparison 396 403	history
T36	Eq-Temporal-Period 396 403	history
T37	Eq-Comparison 412 419	History
T38	Eq-Temporal-Period 412 419	History
T39	Condition 423 444	myocardial infarction
T40	Condition-Name 423 444	myocardial infarction
T41	Condition 448 470	ischemic heart disease
T42	Condition-Name 448 470	ischemic heart disease
T43	Eq-Comparison 471 484	within 1 year
T44	Eq-Operator 471 477	within
T45	Eq-Value 478 479	1
T46	Eq-Temporal-Unit 480 484	year
T47	Eq-Comparison 487 513	within a window of 18 days
T48	Eq-Operator 487 493	within
T49	Eq-Value 506 508	18
T50	Eq-Temporal-Unit 509 513	days
T51	Eq-Comparison 523 528	first
T52	Eq-Temporal-Recency 523 528	first
T53	Study 529 534	study
T54	Drug 535 539	drug
T55	Modifier 558 570	Uncontrolled
T56	Condition 571 581	arrhythmia
T57	Condition-Name 571 581	arrhythmia
T58	Eq-Comparison 585 592	History
T59	Eq-Temporal-Period 585 592	History
T60	Condition 596 622	congenital QT prolongation
T61	Condition-Name 596 622	congenital QT prolongation
T62	Procedure 626 629	ECG
T63	Procedure-Name 626 629	ECG
T64	Eq-Comparison 655 661	active
T65	Eq-Temporal-Period 655 661	active
T66	Condition 662 684	ischemic heart disease
T67	Condition-Name 662 684	ischemic heart disease
T68	Observation 688 714	New York Heart Association
T69	Observation-Name 688 714	New York Heart Association
T70	Eq-Comparison 715 730	Class III or IV
T71	Eq-Unit 715 720	Class
T72	Eq-Value 721 724	III
T73	Eq-Value 728 730	IV
T74	Condition 731 746	cardiac disease
T75	Condition-Name 731 746	cardiac disease
T76	Modifier 750 762	Uncontrolled
T77	Condition 763 775	hypertension
T78	Condition-Name 763 775	hypertension
T79	Observation 778 792	blood pressure
T80	Observation-Name 778 792	blood pressure
T81	Eq-Comparison 806 828	greater than 150 mm Hg
T82	Eq-Operator 806 818	greater than
T83	Eq-Value 819 822	150
T84	Eq-Unit 823 828	mm Hg
T85	Observation 829 837	systolic
T86	Eq-Comparison 842 851	100 mm Hg
T87	Eq-Value 842 845	100
T88	Eq-Unit 846 851	mm Hg
T89	Observation 852 861	diastolic
T90	Observation-Name 852 861	diastolic
T91	Drug 874 901	antihypertensive medication
T92	Drug-Name 874 901	antihypertensive medication
T93	Eq-Comparison 924 938	received prior
T94	Eq-Temporal-Period 924 938	received prior
T95	Procedure 939 948	treatment
T96	Drug 954 963	docetaxel
T97	Drug-Name 954 963	docetaxel
T98	Eq-Comparison 968 973	Prior
T99	Eq-Temporal-Period 968 973	Prior
T100	Condition 974 999	transient ischemic attack
T101	Condition-Name 974 999	transient ischemic attack
T102	Observation 1003 1027	cerebrovascular accident
T103	Observation-Name 1003 1027	cerebrovascular accident
T104	Eq-Comparison 1028 1048	within the past year
T105	Eq-Operator 1028 1034	within
T106	Eq-Temporal-Period 1039 1043	past
T107	Eq-Temporal-Unit 1044 1048	year
T108	Eq-Comparison 1051 1069	within an 18 - day
T109	Eq-Operator 1051 1057	within
T110	Eq-Value 1061 1063	18
T111	Eq-Temporal-Unit 1066 1069	day
T112	Observation 1085 1106	neurologic toxicities
T113	Observation-Name 1085 1106	neurologic toxicities
T114	Eq-Comparison 1107 1116	≥ Grade 2
T115	Eq-Operator 1107 1108	≥
T116	Eq-Unit 1109 1114	Grade
T117	Eq-Value 1115 1116	2
T118	Eq-Comparison 1117 1131	within 3 weeks
T119	Eq-Operator 1117 1123	within
T120	Eq-Value 1124 1125	3
T121	Eq-Temporal-Unit 1126 1131	weeks
T122	Study 1135 1148	randomization
T123	Eq-Comparison 1153 1160	History
T124	Eq-Temporal-Period 1153 1160	History
T125	Condition 1164 1184	hemorrhagic diarrhea
T126	Condition-Name 1164 1184	hemorrhagic diarrhea
T127	Condition 1187 1213	inflammatory bowel disease
T128	Condition-Name 1187 1213	inflammatory bowel disease
T129	Eq-Comparison 1217 1223	active
T130	Eq-Temporal-Period 1217 1223	active
T131	Modifier 1224 1236	uncontrolled
T132	Condition 1237 1257	peptic ulcer disease
T133	Condition-Name 1237 1257	peptic ulcer disease
T134	Procedure 1262 1281	Concomitant therapy
T135	Procedure-Name 1274 1281	therapy
T136	Drug 1287 1297	ranitidine
T137	Drug-Name 1287 1297	ranitidine
T138	Drug 1325 1335	omeprazole
T139	Drug-Name 1325 1335	omeprazole
T140	Eq-Comparison 1372 1379	History
T141	Eq-Temporal-Period 1372 1379	History
T142	Condition 1383 1388	ileus
T143	Other 1392 1397	other
T144	Severity 1398 1409	significant
T145	Condition 1410 1435	gastrointestinal disorder
T146	Condition-Name 1410 1435	gastrointestinal disorder
T147	Risk 1445 1455	predispose
T148	Condition 1459 1464	ileus
T149	Acuteness 1468 1475	chronic
T150	Procedure 1476 1494	bowel hypomotility
T151	Condition-Name 1476 1494	bowel hypomotility
T152	Eq-Comparison 1499 1505	Active
T153	Eq-Temporal-Period 1499 1505	Active
T154	Modifier 1506 1528	uncontrolled bacterial
T155	Modifier 1531 1536	viral
T156	Modifier 1542 1548	fungal
T157	Condition 1549 1558	infection
T158	Condition-Name 1549 1558	infection
T159	Assertion 1559 1568	requiring
T160	Procedure 1569 1585	systemic therapy
T161	Procedure-Name 1578 1585	therapy
T162	Condition 1596 1605	infection
T163	Condition-Name 1596 1605	infection
T164	Condition 1611 1639	human immunodeficiency virus
T165	Condition-Name 1611 1639	human immunodeficiency virus
T166	Condition 1642 1645	HIV
T167	Condition-Name 1642 1645	HIV
T168	Eq-Comparison 1651 1657	active
T169	Eq-Temporal-Period 1651 1657	active
T170	Condition 1658 1667	hepatitis
T171	Condition-Name 1658 1667	hepatitis
T172	Eq-Comparison 1691 1696	prior
T173	Eq-Temporal-Period 1691 1696	prior
T174	Condition 1697 1722	hypersensitivity reaction
T175	Condition-Name 1697 1722	hypersensitivity reaction
T176	Drug 1730 1763	product containing polysorbate 80
T177	Observation-Name 1730 1760	product containing polysorbate
T178	Eq-Value 1761 1763	80
T179	Drug 1766 1800	polyoxyethylene 15 hydroxystearate
T180	Modifier 1803 1830	Macrogol 15 hydroxystearate
T181	Modifier 1833 1840	Solutol
T182	Condition 1841 1843	HS
T183	Modifier 1849 1858	Kolliphor
T184	Condition 1859 1861	HS
T185	Condition-Name 1859 1861	HS
T186	Life-Stage-And-Gender 1871 1877	Female
T187	Condition 1893 1901	pregnant
T188	Condition-Name 1893 1901	pregnant
T189	Condition 1905 1914	lactating
T190	Condition-Name 1905 1914	lactating
T191	Eq-Comparison 1919 1925	Second
T192	Eq-Value 1919 1925	Second
T193	Condition 1926 1936	malignancy
T194	Condition-Name 1926 1936	malignancy
T195	Exception 1937 1943	unless
T196	Eq-Comparison 1961 1970	> 5 years
T197	Eq-Operator 1961 1962	>
T198	Eq-Value 1963 1964	5
T199	Eq-Temporal-Unit 1965 1970	years
T200	Negation 1975 1978	Non
T201	Modifier 1981 1994	melanoma skin
T202	Condition 1995 2001	cancer
T203	Condition-Name 1995 2001	cancer
T204	Condition 2005 2014	carcinoma
T205	Condition-Name 2005 2014	carcinoma
T206	Modifier 2030 2036	cervix
T207	Procedure 2037 2044	treated
T208	Procedure 2050 2065	curative intent
T209	Negation 2069 2072	not
T210	Condition 2096 2114	medical conditions
T211	Assertion 2154 2159	would
T212	Stability 2167 2176	excessive
T213	Risk 2177 2181	risk
T214	Condition 2216 2226	conditions
T215	Modifier 2235 2247	uncontrolled
T216	Condition 2248 2256	diabetes
T217	Condition-Name 2248 2256	diabetes
T218	Condition 2259 2268	infection
T219	Condition-Name 2259 2268	infection
T220	Assertion 2269 2278	requiring
T221	Procedure 2279 2316	parenteral anti - infective treatment
T222	Procedure-Name 2290 2316	anti - infective treatment
T223	Condition 2319 2332	liver failure
T224	Condition-Name 2319 2332	liver failure
T225	Condition 2339 2360	altered mental status
T226	Condition-Name 2339 2360	altered mental status
T227	Condition 2368 2389	psychiatric condition
T228	Condition-Name 2368 2389	psychiatric condition
T229	Stability 2401 2410	interfere
A1	Eq-Operator-Value T14 LTEQ
A2	Eq-Temporal-Unit-Value T16 week
A3	Severity-Value T19 severe
A4	Eq-Operator-Value T26 LTEQ
A5	Eq-Temporal-Unit-Value T28 week
A6	Eq-Temporal-Recency-Value T30 first-time
A7	Severity-Value T33 severe
A8	Eq-Temporal-Period-Value T36 past
A9	Eq-Temporal-Period-Value T38 past
A10	Eq-Operator-Value T44 LTEQ
A11	Eq-Temporal-Unit-Value T46 year
A12	Eq-Operator-Value T48 LTEQ
A13	Eq-Temporal-Unit-Value T50 day
A14	Eq-Temporal-Recency-Value T52 first-time
A15	Eq-Temporal-Period-Value T59 past
A16	Eq-Temporal-Period-Value T65 present
A17	Observation-Type-Value E37 clinical-score
A18	Observation-Type-Value E42 vital
A19	Eq-Operator-Value T82 GT
A20	Observation-Type-Value E44 vital
A21	Observation-Type-Value E46 vital
A22	Eq-Temporal-Period-Value T94 past
A23	Eq-Temporal-Period-Value T99 past
A24	Eq-Operator-Value T105 LTEQ
A25	Eq-Temporal-Period-Value T106 past
A26	Eq-Temporal-Unit-Value T107 year
A27	Eq-Operator-Value T109 LTEQ
A28	Eq-Temporal-Unit-Value T111 day
A29	Observation-Type-Value E56 lab
A30	Eq-Operator-Value T115 GTEQ
A31	Eq-Operator-Value T119 LTEQ
A32	Eq-Temporal-Unit-Value T121 week
A33	Eq-Temporal-Period-Value T124 past
A34	Eq-Temporal-Period-Value T130 present
A35	Eq-Temporal-Period-Value T141 past
A36	Severity-Value T144 severe
A37	Acuteness-Type-Value T149 chronic
A38	Eq-Temporal-Period-Value T153 present
A39	Assertion-Type-Value E81 hypothetical
A40	Eq-Temporal-Period-Value T169 present
A41	Eq-Temporal-Period-Value T173 past
A42	Life-Stage-And-Gender-Type T186 female
A43	Eq-Operator-Value T197 GT
A44	Eq-Temporal-Unit-Value T199 year
A45	Assertion-Type-Value E112 hypothetical
A46	Stability-Value T212 change
A47	Assertion-Type-Value E118 hypothetical
A48	Stability-Value T229 change
R1	Or Arg1:T1 Arg2:T3
R2	Or Arg1:T5 Arg2:T6
R3	Or Arg1:T6 Arg2:T7
R4	Or Arg1:T7 Arg2:T10
R5	Or Arg1:T11 Arg2:T12
R6	Before Arg1:T13 Arg2:T17
R7	Before Arg1:T25 Arg2:T29
R8	Before Arg1:T25 Arg2:T31
R9	Or Arg1:T39 Arg2:T41
R10	Before Arg1:T41 Arg2:T51
R11	Equivalent-To Arg1:T47 Arg2:T43
R12	Before Arg1:T43 Arg2:T51
R13	Before Arg1:T43 Arg2:T53
R14	Found-By Arg1:T66 Arg2:T62
R15	Equivalent-To Arg1:T79 Arg2:T77
R16	Equivalent-To Arg1:T85 Arg2:T77
R17	Equivalent-To Arg1:T85 Arg2:T79
R18	Or Arg1:T85 Arg2:T89
R19	Using Arg1:T95 Arg2:T96
R20	Or Arg1:T100 Arg2:T102
R21	Equivalent-To Arg1:T108 Arg2:T104
R22	Before Arg1:T118 Arg2:T122
R23	Or Arg1:T125 Arg2:T127
R24	Or Arg1:T127 Arg2:T132
R25	Using Arg1:T134 Arg2:T136
R26	Or Arg1:T142 Arg2:T145
R27	Caused-By Arg1:T147 Arg2:T145
R28	Or Arg1:T154 Arg2:T155
R29	Or Arg1:T155 Arg2:T156
R30	Treatment-For Arg1:T160 Arg2:T157
R31	And Arg1:T162 Arg2:T164
R32	Or Arg1:T162 Arg2:T170
R33	Abbrev-Of Arg1:T166 Arg2:T164
R34	Or Arg1:T166 Arg2:T170
R35	Caused-By Arg1:T174 Arg2:T176
R36	Caused-By Arg1:T174 Arg2:T179
R37	Or Arg1:T176 Arg2:T179
R38	Or Arg1:T179 Arg2:T180
R39	Equivalent-To Arg1:T182 Arg2:T180
R40	Equivalent-To Arg1:T184 Arg2:T180
R41	Or Arg1:T181 Arg2:T183
R42	Or Arg1:T182 Arg2:T184
R43	And Arg1:T186 Arg2:T187
R44	Or Arg1:T187 Arg2:T189
R45	Or Arg1:T202 Arg2:T204
R46	Treatment-For Arg1:T207 Arg2:T204
R47	Treatment-For Arg1:T208 Arg2:T204
R48	Using Arg1:T207 Arg2:T208
R49	Caused-By Arg1:T212 Arg2:T210
R50	Caused-By Arg1:T213 Arg2:T210
R51	Example-Of Arg1:T216 Arg2:T214
R52	Example-Of Arg1:T218 Arg2:T214
R53	Example-Of Arg1:T223 Arg2:T214
R54	Example-Of Arg1:T225 Arg2:T214
R55	Example-Of Arg1:T227 Arg2:T214
R56	Or Arg1:T216 Arg2:T218
R57	Treatment-For Arg1:T221 Arg2:T218
R58	Or Arg1:T221 Arg2:T223
R59	Or Arg1:T225 Arg2:T227
R60	Caused-By Arg1:T229 Arg2:T227
E1	Procedure:T1
E2	Procedure:T3
E3	Modifier:T5
E4	Modifier:T6
E5	Procedure:T7
E6	Study:T9 Study-Of:E7
E7	Drug:T10 Temporality:E10
E8	Modifier:T11
E9	Modifier:T12
E10	Eq-Comparison:T13
E11	Study:T17 Study-Of:E12
E12	Drug:T18
E13	Procedure:T20 Severity:T19
E14	Exception:T22 From:E13 Except:E15
E15	Procedure:T23
E16	Eq-Comparison:T25
E17	Eq-Comparison:T29
E18	Study:T31 Temporality:E17 Study-Of:E19
E19	Drug:T32 Temporality:E17
E20	Condition:T34 Severity:T33 Temporality:E21
E21	Eq-Comparison:T35
E22	Eq-Comparison:T37
E23	Condition:T39 Temporality:E22
E24	Condition:T41 Temporality:E25 Temporality:E26
E25	Eq-Comparison:T43
E26	Eq-Comparison:T47
E27	Eq-Comparison:T51
E28	Study:T53 Temporality:E27 Study-Of:E29
E29	Drug:T54 Temporality:E27
E30	Modifier:T55 Modifies:E31
E31	Condition:T56
E32	Eq-Comparison:T58
E33	Condition:T60 Temporality:E32
E34	Procedure:T62
E35	Eq-Comparison:T64
E36	Condition:T66 Temporality:E35
E37	Observation:T68 Numeric-Filter:E38
E38	Eq-Comparison:T70
E39	Condition:T74 Stage:E38
E40	Modifier:T76 Modifies:E41
E41	Condition:T77
E42	Observation:T79 Numeric-Filter:E43
E43	Eq-Comparison:T81
E44	Observation:T85 Numeric-Filter:E43 Numeric-Filter:E45
E45	Eq-Comparison:T86
E46	Observation:T89 Numeric-Filter:E45
E47	Drug:T91
E48	Eq-Comparison:T93
E49	Procedure:T95 Temporality:E48
E50	Drug:T96
E51	Eq-Comparison:T98
E52	Condition:T100 Temporality:E51
E53	Observation:T102 Temporality:E54 Temporality:E55
E54	Eq-Comparison:T104
E55	Eq-Comparison:T108
E56	Observation:T112 Numeric-Filter:E57 Temporality:E58
E57	Eq-Comparison:T114
E58	Eq-Comparison:T118
E59	Study:T122
E60	Eq-Comparison:T123
E61	Condition:T125 Temporality:E60
E62	Condition:T127
E63	Eq-Comparison:T129
E64	Modifier:T131 Modifies:E65
E65	Condition:T132 Temporality:E63
E66	Procedure:T134
E67	Drug:T136
E68	Drug:T138
E69	Eq-Comparison:T140
E70	Condition:T142 Temporality:E69 Severity:T144
E71	Other:T143 Is-Other:E72
E72	Condition:T145 Severity:T144
E73	Risk:T147 Risk-For:E74
E74	Condition:T148
E75	Procedure:T150
E76	Eq-Comparison:T152
E77	Modifier:T154 Modifies:E80
E78	Modifier:T155 Modifies:E80
E79	Modifier:T156 Modifies:E80
E80	Condition:T157 Temporality:E76
E81	Assertion:T159 Asserted:E82
E82	Procedure:T160
E83	Condition:T162
E84	Condition:T164
E85	Condition:T166
E86	Eq-Comparison:T168
E87	Condition:T170 Temporality:E86
E88	Eq-Comparison:T172
E89	Condition:T174 Temporality:E88
E90	Drug:T176
E91	Drug:T179
E92	Modifier:T180
E93	Modifier:T181 Modifies:E94
E94	Condition:T182
E95	Modifier:T183 Modifies:E96
E96	Condition:T184
E97	Condition:T187
E98	Condition:T189
E99	Eq-Comparison:T191
E100	Condition:T193 Minimum-Count:E99 Duration:E102
E101	Exception:T195 From:E100
E102	Eq-Comparison:T196
E103	Negation:T200 Negates:E104
E104	Modifier:T201 Modifies:E105
E105	Condition:T202
E106	Condition:T204
E107	Modifier:T206 Modifies:E106
E108	Procedure:T207
E109	Procedure:T208
E110	Negation:T209 Negates:E106 Negates:E108
E111	Condition:T210
E112	Assertion:T211 Asserted:T212 Asserted:E113
E113	Risk:T213 Stability:T212
E114	Condition:T214
E115	Modifier:T215 Modifies:E116
E116	Condition:T216
E117	Condition:T218
E118	Assertion:T220 Asserted:E119
E119	Procedure:T221
E120	Condition:T223
E121	Condition:T225
E122	Condition:T227
